Selected research
Market Outlook & Growth Opportunities
Global Plasmid DNA Preparation Service Market Outlook and Growth Opportunities 2026
Market perspective
The global Plasmid DNA Preparation Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Plasmid DNA Preparation Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Plasmid DNA Preparation Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Plasmid DNA Preparation Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Plasmid DNA Preparation Service market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Plasmid DNA Preparation Service market include Aldevron, GenScript, Plasmid Factory, VGXI Inc., ReciBioPharm, QHP Capital, Altogen Biosystems, Charles River and Esco Aster, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global Plasmid DNA Preparation Service market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Plasmid DNA Preparation Service and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Plasmid DNA Preparation Service revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Plasmid DNA Preparation Service market.
Plasmid DNA Preparation Service Segment by Company
Aldevron
GenScript
Plasmid Factory
VGXI Inc.
ReciBioPharm
QHP Capital
Altogen Biosystems
Charles River
Esco Aster
Takara Bio
InvivoGen
AmplifyBio
Medigene Sdn Bhd
Biovian
Mirus Bio
AGC Biologics
GenePharma
Polyplus Transfection
Plasmid DNA Preparation Service Segment by Type
F-plasmids
R-plasmids
Col Plasmids
Virulence Plasmids
Degradative Plasmids
Plasmid DNA Preparation Service Segment by Application
Transfection
Recombinant DNA Technology
Gene Therapy
Others
Plasmid DNA Preparation Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Plasmid DNA Preparation Service status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Plasmid DNA Preparation Service key companies, revenue, market share, and recent developments.
3. To split the Plasmid DNA Preparation Service breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Plasmid DNA Preparation Service market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Plasmid DNA Preparation Service significant trends, drivers, influence factors in global and regions.
6. To analyze Plasmid DNA Preparation Service competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Plasmid DNA Preparation Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Plasmid DNA Preparation Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Plasmid DNA Preparation Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Plasmid DNA Preparation Service industry.
Chapter 3: Detailed analysis of Plasmid DNA Preparation Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Plasmid DNA Preparation Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Plasmid DNA Preparation Service in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- F-plasmids
- R-plasmids
- Col Plasmids
- Virulence Plasmids
- Degradative Plasmids
Applications
- Transfection
- Recombinant DNA Technology
- Gene Therapy
- Others
Companies covered
- Aldevron
- GenScript
- Plasmid Factory
- VGXI Inc.
- ReciBioPharm
- QHP Capital
- Altogen Biosystems
- Charles River
- Esco Aster
- Takara Bio
- InvivoGen
- AmplifyBio
- Medigene Sdn Bhd
- Biovian
- Mirus Bio
- AGC Biologics
- GenePharma
- Polyplus Transfection
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Plasmid DNA Preparation Service Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Plasmid DNA Preparation Service Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Plasmid DNA Preparation Service Market Dynamics
- 2.1 Plasmid DNA Preparation Service Industry Trends
- 2.2 Plasmid DNA Preparation Service Industry Drivers
- 2.3 Plasmid DNA Preparation Service Industry Opportunities and Challenges
- 2.4 Plasmid DNA Preparation Service Industry Restraints
3 Plasmid DNA Preparation Service Market by Company
- 3.1 Global Plasmid DNA Preparation Service Company Revenue Ranking in 2025
- 3.2 Global Plasmid DNA Preparation Service Revenue by Company (2021-2026)
- 3.3 Global Plasmid DNA Preparation Service Company Ranking (2024-2026)
- 3.4 Global Plasmid DNA Preparation Service Company Manufacturing Base and Headquarters
- 3.5 Global Plasmid DNA Preparation Service Company Product Type and Application
- 3.6 Global Plasmid DNA Preparation Service Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global Plasmid DNA Preparation Service Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 Plasmid DNA Preparation Service Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 Plasmid DNA Preparation Service Market by Type
- 4.1 Plasmid DNA Preparation Service Type Introduction
- 4.1.1 F-plasmids
- 4.1.2 R-plasmids
- 4.1.3 Col Plasmids
- 4.1.4 Virulence Plasmids
- 4.1.5 Degradative Plasmids
- 4.2 Global Plasmid DNA Preparation Service Sales Value by Type
- 4.2.1 Global Plasmid DNA Preparation Service Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Plasmid DNA Preparation Service Sales Value by Type (2021-2032)
- 4.2.3 Global Plasmid DNA Preparation Service Sales Value Share by Type (2021-2032)
5 Plasmid DNA Preparation Service Market by Application
- 5.1 Plasmid DNA Preparation Service Application Introduction
- 5.1.1 Transfection
- 5.1.2 Recombinant DNA Technology
- 5.1.3 Gene Therapy
- 5.1.4 Others
- 5.2 Global Plasmid DNA Preparation Service Sales Value by Application
- 5.2.1 Global Plasmid DNA Preparation Service Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Plasmid DNA Preparation Service Sales Value by Application (2021-2032)
- 5.2.3 Global Plasmid DNA Preparation Service Sales Value Share by Application (2021-2032)
6 Plasmid DNA Preparation Service Regional Value Analysis
- 6.1 Global Plasmid DNA Preparation Service Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global Plasmid DNA Preparation Service Sales Value by Region (2021-2032)
- 6.2.1 Global Plasmid DNA Preparation Service Sales Value by Region: 2021-2026
- 6.2.2 Global Plasmid DNA Preparation Service Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Plasmid DNA Preparation Service Sales Value (2021-2032)
- 6.3.2 North America Plasmid DNA Preparation Service Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe Plasmid DNA Preparation Service Sales Value (2021-2032)
- 6.4.2 Europe Plasmid DNA Preparation Service Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific Plasmid DNA Preparation Service Sales Value (2021-2032)
- 6.5.2 Asia-Pacific Plasmid DNA Preparation Service Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America Plasmid DNA Preparation Service Sales Value (2021-2032)
- 6.6.2 South America Plasmid DNA Preparation Service Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa Plasmid DNA Preparation Service Sales Value (2021-2032)
- 6.7.2 Middle East & Africa Plasmid DNA Preparation Service Sales Value Share by Country, 2025 VS 2032
7 Plasmid DNA Preparation Service Country-level Value Analysis
- 7.1 Global Plasmid DNA Preparation Service Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global Plasmid DNA Preparation Service Sales Value by Country (2021-2032)
- 7.2.1 Global Plasmid DNA Preparation Service Sales Value by Country (2021-2026)
- 7.2.2 Global Plasmid DNA Preparation Service Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA Plasmid DNA Preparation Service Sales Value Growth Rate (2021-2032)
- 7.3.2 USA Plasmid DNA Preparation Service Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA Plasmid DNA Preparation Service Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada Plasmid DNA Preparation Service Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada Plasmid DNA Preparation Service Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada Plasmid DNA Preparation Service Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico Plasmid DNA Preparation Service Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico Plasmid DNA Preparation Service Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico Plasmid DNA Preparation Service Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany Plasmid DNA Preparation Service Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany Plasmid DNA Preparation Service Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany Plasmid DNA Preparation Service Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France Plasmid DNA Preparation Service Sales Value Growth Rate (2021-2032)
- 7.7.2 France Plasmid DNA Preparation Service Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France Plasmid DNA Preparation Service Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. Plasmid DNA Preparation Service Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. Plasmid DNA Preparation Service Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. Plasmid DNA Preparation Service Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy Plasmid DNA Preparation Service Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy Plasmid DNA Preparation Service Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy Plasmid DNA Preparation Service Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain Plasmid DNA Preparation Service Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain Plasmid DNA Preparation Service Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain Plasmid DNA Preparation Service Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia Plasmid DNA Preparation Service Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia Plasmid DNA Preparation Service Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia Plasmid DNA Preparation Service Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands Plasmid DNA Preparation Service Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands Plasmid DNA Preparation Service Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands Plasmid DNA Preparation Service Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries Plasmid DNA Preparation Service Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries Plasmid DNA Preparation Service Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries Plasmid DNA Preparation Service Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China Plasmid DNA Preparation Service Sales Value Growth Rate (2021-2032)
- 7.14.2 China Plasmid DNA Preparation Service Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China Plasmid DNA Preparation Service Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan Plasmid DNA Preparation Service Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan Plasmid DNA Preparation Service Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan Plasmid DNA Preparation Service Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea Plasmid DNA Preparation Service Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea Plasmid DNA Preparation Service Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea Plasmid DNA Preparation Service Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India Plasmid DNA Preparation Service Sales Value Growth Rate (2021-2032)
- 7.17.2 India Plasmid DNA Preparation Service Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India Plasmid DNA Preparation Service Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia Plasmid DNA Preparation Service Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia Plasmid DNA Preparation Service Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia Plasmid DNA Preparation Service Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia Plasmid DNA Preparation Service Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia Plasmid DNA Preparation Service Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia Plasmid DNA Preparation Service Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil Plasmid DNA Preparation Service Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil Plasmid DNA Preparation Service Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil Plasmid DNA Preparation Service Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina Plasmid DNA Preparation Service Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina Plasmid DNA Preparation Service Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina Plasmid DNA Preparation Service Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile Plasmid DNA Preparation Service Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile Plasmid DNA Preparation Service Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile Plasmid DNA Preparation Service Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia Plasmid DNA Preparation Service Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia Plasmid DNA Preparation Service Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia Plasmid DNA Preparation Service Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru Plasmid DNA Preparation Service Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru Plasmid DNA Preparation Service Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru Plasmid DNA Preparation Service Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia Plasmid DNA Preparation Service Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia Plasmid DNA Preparation Service Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia Plasmid DNA Preparation Service Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel Plasmid DNA Preparation Service Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel Plasmid DNA Preparation Service Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel Plasmid DNA Preparation Service Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE Plasmid DNA Preparation Service Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE Plasmid DNA Preparation Service Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE Plasmid DNA Preparation Service Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey Plasmid DNA Preparation Service Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey Plasmid DNA Preparation Service Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey Plasmid DNA Preparation Service Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran Plasmid DNA Preparation Service Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran Plasmid DNA Preparation Service Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran Plasmid DNA Preparation Service Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt Plasmid DNA Preparation Service Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt Plasmid DNA Preparation Service Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt Plasmid DNA Preparation Service Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Aldevron
- 8.1.1 Aldevron Company Information
- 8.1.2 Aldevron Business Overview
- 8.1.3 Aldevron Plasmid DNA Preparation Service Revenue and Gross Margin (2021-2026)
- 8.1.4 Aldevron Plasmid DNA Preparation Service Product Portfolio
- 8.1.5 Aldevron Recent Developments
- 8.2 GenScript
- 8.2.1 GenScript Company Information
- 8.2.2 GenScript Business Overview
- 8.2.3 GenScript Plasmid DNA Preparation Service Revenue and Gross Margin (2021-2026)
- 8.2.4 GenScript Plasmid DNA Preparation Service Product Portfolio
- 8.2.5 GenScript Recent Developments
- 8.3 Plasmid Factory
- 8.3.1 Plasmid Factory Company Information
- 8.3.2 Plasmid Factory Business Overview
- 8.3.3 Plasmid Factory Plasmid DNA Preparation Service Revenue and Gross Margin (2021-2026)
- 8.3.4 Plasmid Factory Plasmid DNA Preparation Service Product Portfolio
- 8.3.5 Plasmid Factory Recent Developments
- 8.4 VGXI Inc.
- 8.4.1 VGXI Inc. Company Information
- 8.4.2 VGXI Inc. Business Overview
- 8.4.3 VGXI Inc. Plasmid DNA Preparation Service Revenue and Gross Margin (2021-2026)
- 8.4.4 VGXI Inc. Plasmid DNA Preparation Service Product Portfolio
- 8.4.5 VGXI Inc. Recent Developments
- 8.5 ReciBioPharm
- 8.5.1 ReciBioPharm Company Information
- 8.5.2 ReciBioPharm Business Overview
- 8.5.3 ReciBioPharm Plasmid DNA Preparation Service Revenue and Gross Margin (2021-2026)
- 8.5.4 ReciBioPharm Plasmid DNA Preparation Service Product Portfolio
- 8.5.5 ReciBioPharm Recent Developments
- 8.6 QHP Capital
- 8.6.1 QHP Capital Company Information
- 8.6.2 QHP Capital Business Overview
- 8.6.3 QHP Capital Plasmid DNA Preparation Service Revenue and Gross Margin (2021-2026)
- 8.6.4 QHP Capital Plasmid DNA Preparation Service Product Portfolio
- 8.6.5 QHP Capital Recent Developments
- 8.7 Altogen Biosystems
- 8.7.1 Altogen Biosystems Company Information
- 8.7.2 Altogen Biosystems Business Overview
- 8.7.3 Altogen Biosystems Plasmid DNA Preparation Service Revenue and Gross Margin (2021-2026)
- 8.7.4 Altogen Biosystems Plasmid DNA Preparation Service Product Portfolio
- 8.7.5 Altogen Biosystems Recent Developments
- 8.8 Charles River
- 8.8.1 Charles River Company Information
- 8.8.2 Charles River Business Overview
- 8.8.3 Charles River Plasmid DNA Preparation Service Revenue and Gross Margin (2021-2026)
- 8.8.4 Charles River Plasmid DNA Preparation Service Product Portfolio
- 8.8.5 Charles River Recent Developments
- 8.9 Esco Aster
- 8.9.1 Esco Aster Company Information
- 8.9.2 Esco Aster Business Overview
- 8.9.3 Esco Aster Plasmid DNA Preparation Service Revenue and Gross Margin (2021-2026)
- 8.9.4 Esco Aster Plasmid DNA Preparation Service Product Portfolio
- 8.9.5 Esco Aster Recent Developments
- 8.10 Takara Bio
- 8.10.1 Takara Bio Company Information
- 8.10.2 Takara Bio Business Overview
- 8.10.3 Takara Bio Plasmid DNA Preparation Service Revenue and Gross Margin (2021-2026)
- 8.10.4 Takara Bio Plasmid DNA Preparation Service Product Portfolio
- 8.10.5 Takara Bio Recent Developments
- 8.11 InvivoGen
- 8.11.1 InvivoGen Company Information
- 8.11.2 InvivoGen Business Overview
- 8.11.3 InvivoGen Plasmid DNA Preparation Service Revenue and Gross Margin (2021-2026)
- 8.11.4 InvivoGen Plasmid DNA Preparation Service Product Portfolio
- 8.11.5 InvivoGen Recent Developments
- 8.12 AmplifyBio
- 8.12.1 AmplifyBio Company Information
- 8.12.2 AmplifyBio Business Overview
- 8.12.3 AmplifyBio Plasmid DNA Preparation Service Revenue and Gross Margin (2021-2026)
- 8.12.4 AmplifyBio Plasmid DNA Preparation Service Product Portfolio
- 8.12.5 AmplifyBio Recent Developments
- 8.13 Medigene Sdn Bhd
- 8.13.1 Medigene Sdn Bhd Company Information
- 8.13.2 Medigene Sdn Bhd Business Overview
- 8.13.3 Medigene Sdn Bhd Plasmid DNA Preparation Service Revenue and Gross Margin (2021-2026)
- 8.13.4 Medigene Sdn Bhd Plasmid DNA Preparation Service Product Portfolio
- 8.13.5 Medigene Sdn Bhd Recent Developments
- 8.14 Biovian
- 8.14.1 Biovian Company Information
- 8.14.2 Biovian Business Overview
- 8.14.3 Biovian Plasmid DNA Preparation Service Revenue and Gross Margin (2021-2026)
- 8.14.4 Biovian Plasmid DNA Preparation Service Product Portfolio
- 8.14.5 Biovian Recent Developments
- 8.15 Mirus Bio
- 8.15.1 Mirus Bio Company Information
- 8.15.2 Mirus Bio Business Overview
- 8.15.3 Mirus Bio Plasmid DNA Preparation Service Revenue and Gross Margin (2021-2026)
- 8.15.4 Mirus Bio Plasmid DNA Preparation Service Product Portfolio
- 8.15.5 Mirus Bio Recent Developments
- 8.16 AGC Biologics
- 8.16.1 AGC Biologics Company Information
- 8.16.2 AGC Biologics Business Overview
- 8.16.3 AGC Biologics Plasmid DNA Preparation Service Revenue and Gross Margin (2021-2026)
- 8.16.4 AGC Biologics Plasmid DNA Preparation Service Product Portfolio
- 8.16.5 AGC Biologics Recent Developments
- 8.17 GenePharma
- 8.17.1 GenePharma Company Information
- 8.17.2 GenePharma Business Overview
- 8.17.3 GenePharma Plasmid DNA Preparation Service Revenue and Gross Margin (2021-2026)
- 8.17.4 GenePharma Plasmid DNA Preparation Service Product Portfolio
- 8.17.5 GenePharma Recent Developments
- 8.18 Polyplus Transfection
- 8.18.1 Polyplus Transfection Company Information
- 8.18.2 Polyplus Transfection Business Overview
- 8.18.3 Polyplus Transfection Plasmid DNA Preparation Service Revenue and Gross Margin (2021-2026)
- 8.18.4 Polyplus Transfection Plasmid DNA Preparation Service Product Portfolio
- 8.18.5 Polyplus Transfection Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst